Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations

Abu, 2014, Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro, PloS One, 9, e105244, 10.1371/journal.pone.0105244 Back, 2013, The importance of drug-drug interactions in the DAA era, Dig. Liver Dis., 45, S343, 10.1016/j.dld.2013.07.008 Ekstrand, 2015, In vitro gender-dependent inhibition of porcine cytochrome p450 activity by selected flavonoids and phenolic acids, BioMed Res. Int., 7 Borkar, 2015, Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry, J. Pharm. Biomed. Anal., 102, 386, 10.1016/j.jpba.2014.10.008 Chen, 2014, Evaluation of enzyme inhibition kinetics in drug-drug interactions, Chem.-Biol. Interact., 222C, 133, 10.1016/j.cbi.2014.10.010 Dostalek, 2005, Effect of St John’s wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver, Life Sci., 78, 239, 10.1016/j.lfs.2005.04.055 Fasinu, 2014, The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction, Afr. J. Tradit. Complement. Altern. Med., 11, 54, 10.4314/ajtcam.v11i4.9 Fu, 2012, Kavalactone metabolism in rat liver microsomes, Phytother. Research, 26, 1057, 10.1002/ptr.3695 Galeazzi, 2012, Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study, J. Mol. Model., 18, 1153, 10.1007/s00894-011-1144-y Kim, 2013, Effects of beta-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism, Cancer Chemother. Pharmacol., 72, 699, 10.1007/s00280-013-2230-x Kwon, 2013, Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-kappaB and AP-1 activation in RAW 264.7 macrophages, Food Chem. Toxicol., 58, 479, 10.1016/j.fct.2013.05.031 Li, 2012, Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice, PloS One, 7, e31213, 10.1371/journal.pone.0031213 Li, 2013, In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates, Chem.-Biol. Interact., 204, 140, 10.1016/j.cbi.2013.05.007 Li, 2014, Dietary feeding of flavokawain A, a kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice, Toxicol. Rep., 1, 2, 10.1016/j.toxrep.2014.02.002 Liu, 2013, Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model, Cancer Prev. Res., 6, 1365, 10.1158/1940-6207.CAPR-13-0219 Mathews, 2005, Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro, Drug Metab. Dispos., 33, 1555, 10.1124/dmd.105.004317 Mohamad, 2010, Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice, Eur. J. Pharmacol., 647, 103, 10.1016/j.ejphar.2010.08.030 Sarris, 2012, The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study, Hum. Psychopharmacol., 27, 262, 10.1002/hup.2216 Seely, 2010, Clinically based evidence of drug–herb interactions: a systematic review, Expert Opin. Drug Saf., 9, 45 Spaggiari, 2014, A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies, J. Pharm. Biomed. Anal., 101, 221, 10.1016/j.jpba.2014.03.018 Tang, 2011, Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes, Toxicol. Lett., 202, 47, 10.1016/j.toxlet.2011.01.019 Tang, 2008, Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53, Cancer Prev. Res., 1, 439, 10.1158/1940-6207.CAPR-08-0165 Tarbah, 2003, Kinetics of kavain and its metabolites after oral application, J. Chromatogr. B, 789, 115, 10.1016/S1570-0232(03)00046-1 Tassaneeyakul, 2000, Inhibition selectivity of grapefruit juice components on human cytochromes P450, Arch. Biochem. Biophys., 378, 356, 10.1006/abbi.2000.1835 Teschke, 2010, Kava hepatotoxicity: pathogenetic aspects and prospective considerations, Liver Int., 30, 1270, 10.1111/j.1478-3231.2010.02308.x Teschke, 2011, Kava hepatotoxicity solution: a six-point plan for new kava standardization, Phytomedicine, 18, 96, 10.1016/j.phymed.2010.10.002 Teschke, 2009, Kava hepatotoxicity: regulatory data selection and causality assessment, Dig. Liver Dis., 41, 891, 10.1016/j.dld.2009.04.003 Vandenbroucke, 2015, Comparative analysis of genetic variation in kava (Piper methysticum) assessed by SSR and DArT reveals zygotic foundation and clonal diversification, Genome, 58, 1, 10.1139/gen-2014-0166 Verbeeck, 2008, Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction, Eur. J. Clin. Pharmacol., 64, 1147, 10.1007/s00228-008-0553-z Wang, 2014, Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction, J. Ethnopharmacol., 156, 175, 10.1016/j.jep.2014.08.044 Wang, 2015, Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots, J. Ethnopharmacol., 166, 66, 10.1016/j.jep.2015.03.002 Wu, 2015, Human microsomal cyttrochrome P450-mediated reduction of oxysophocarpine, an active and highly toxic constituent derived from Sophora flavescens species, and its intestinal absorption and metabolism in rat, Fitoterapia, 105, 26, 10.1016/j.fitote.2015.05.021 Wu, 2014, The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects, Eur. J. Clin. Pharmacol., 70, 57, 10.1007/s00228-013-1573-x Yu, 2013, In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography–mass spectrometry, J. Chromatogr. B, 941, 31, 10.1016/j.jchromb.2013.09.029 Zenger, 2015, Biotransformation of flavokawains A, B, and C, chalcones from kava (Piper methysticum), by human liver microsomes, J. Agric. Food Chem., 63, 6376, 10.1021/acs.jafc.5b01858 Zhou, 2013, Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes, Phytomedicine, 20, 367, 10.1016/j.phymed.2012.09.021